Bitesize Bio
The End of the Beginning for Retrosynthetic Planning
23 views
In this webinar, you will learn about:
how SYNTHIA™ was developed
the innovations that have improved the technology
the benchtop validations that have made the tool more useful.
SYNTHIA™ takes a unique approach to building an expert database of known reaction rules. It hand codes each transformation, enabling the tool to become a bench chemist’s ally by ‘learning’ chemistry much like a chemist would themselves, and suggesting diverse pathways towards their targets, thus generating ideas and providing cost-effective routes based on each user’s unique needs. As a product of over 15 years of research, this tool is poised not only to improve over time, but also to revolutionize the way chemists design pathways to their complex targets.
The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada.